CVS Health Corporation $CVS Shares Acquired by Vest Financial LLC

Vest Financial LLC increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 39.3% in the 2nd quarter, HoldingsChannel reports. The firm owned 23,268 shares of the pharmacy operator’s stock after purchasing an additional 6,561 shares during the period. Vest Financial LLC’s holdings in CVS Health were worth $1,605,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Hazlett Burt & Watson Inc. grew its stake in CVS Health by 10.9% during the 2nd quarter. Hazlett Burt & Watson Inc. now owns 1,682 shares of the pharmacy operator’s stock worth $117,000 after purchasing an additional 165 shares in the last quarter. Essex Financial Services Inc. lifted its holdings in CVS Health by 0.8% during the 1st quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator’s stock worth $1,403,000 after buying an additional 166 shares during the last quarter. Williams Financial LLC lifted its holdings in CVS Health by 2.5% during the 2nd quarter. Williams Financial LLC now owns 6,923 shares of the pharmacy operator’s stock worth $478,000 after buying an additional 167 shares during the last quarter. Hemington Wealth Management lifted its holdings in CVS Health by 33.7% during the 1st quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator’s stock worth $46,000 after buying an additional 172 shares during the last quarter. Finally, Sumitomo Life Insurance Co. lifted its holdings in CVS Health by 1.0% during the 1st quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator’s stock worth $1,159,000 after buying an additional 174 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts have issued reports on CVS shares. Baird R W raised CVS Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 14th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of CVS Health in a report on Tuesday. Wall Street Zen raised CVS Health from a “hold” rating to a “buy” rating in a report on Sunday, September 21st. The Goldman Sachs Group began coverage on CVS Health in a report on Tuesday. They issued a “buy” rating and a $91.00 target price for the company. Finally, Jefferies Financial Group boosted their target price on CVS Health from $74.00 to $80.00 and gave the company a “buy” rating in a report on Monday, June 30th. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $81.05.

Insider Buying and Selling

In other news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares of the company’s stock, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Stock Up 1.6%

CVS opened at $79.67 on Wednesday. The business has a 50 day moving average price of $72.95 and a two-hundred day moving average price of $67.83. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74. The company has a market cap of $101.05 billion, a PE ratio of 22.25, a P/E/G ratio of 0.87 and a beta of 0.60. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $79.94.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, beating the consensus estimate of $1.46 by $0.35. The firm had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The firm’s revenue was up 8.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be paid a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.3%. CVS Health’s dividend payout ratio is currently 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.